Q32 Bio, Inc. (QTTB)
9.25
+0.40
(+4.52%)
USD |
NASDAQ |
Nov 06, 16:00
9.25
0.00 (0.00%)
After-Hours: 20:00
Q32 Bio Free Cash Flow : -20.07M for Sept. 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2026 | -20.07M |
| June 30, 2026 | -19.83M |
| March 31, 2026 | -27.40M |
| December 31, 2025 | -33.54M |
| September 30, 2025 | -38.79M |
| June 30, 2025 | -54.14M |
| March 31, 2025 | -65.72M |
| December 31, 2024 | -67.79M |
| September 30, 2024 | -67.08M |
| June 30, 2024 | -31.60M |
| March 31, 2024 | -20.73M |
| December 31, 2023 | -18.68M |
| September 30, 2023 | -35.18M |
| June 30, 2023 | -76.01M |
| March 31, 2023 | -95.61M |
| December 31, 2022 | -114.95M |
| September 30, 2022 | -118.51M |
| Date | Value |
|---|---|
| June 30, 2022 | -119.43M |
| March 31, 2022 | -113.34M |
| December 31, 2021 | -112.15M |
| September 30, 2021 | -93.95M |
| June 30, 2021 | -97.13M |
| March 31, 2021 | -100.83M |
| December 31, 2020 | -98.06M |
| September 30, 2020 | -115.56M |
| June 30, 2020 | -113.72M |
| March 31, 2020 | -112.73M |
| December 31, 2019 | -113.19M |
| September 30, 2019 | -107.14M |
| June 30, 2019 | -98.45M |
| March 31, 2019 | -83.76M |
| December 31, 2018 | -67.50M |
| September 30, 2018 | -21.78M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Intellia Therapeutics, Inc. | -348.69M |
| Beam Therapeutics, Inc. | -398.24M |
| Prime Medicine, Inc. | -156.85M |
| Korsana Biosciences, Inc. | -4.517M |
| Prelude Therapeutics, Inc. | -33.26M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -4.418M |
| Cash from Investing (Quarterly) | -0.052M |
| Cash from Financing (Quarterly) | 187.79M |
| Free Cash Flow Per Share (Quarterly) | -0.1314 |
| Free Cash Flow to Equity (Quarterly) | -4.296M |
| Free Cash Flow to Firm (Quarterly) | -4.47M |
| Free Cash Flow Yield | -10.71% |